AI assistant
Sending…
CYCLOPHARM LIMITED — Director's Dealing 2017
Jun 22, 2017
64741_rns_2017-06-22_7466cdcb-4761-49b1-984b-3011f2aa6dfb.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y
Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01Amended 01/01/11
Name of entity |
Cyclopharm Limited |
|---|---|
ABN |
74 116 931 250 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the
director for the purposes of section 205G of the Corporations Act.
Name of Director |
Thomas Arthur McDONALD |
|---|---|
Date of last notice |
3 April 2017 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in
this part.
Direct or indirect interest |
Indirect interest |
|---|---|
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to therelevant interest. |
Mrs. R McDonald< spouse of Non-Executive Director > |
Date of change |
21 June 2017 |
No. of securities held prior to change |
Nil |
Class |
Ordinary Shares |
Number acquired |
19,830 |
Number disposed |
Nil |
Value/ConsiderationNote: If consideration is non-cash, provide details andestimated valuation |
$16,162 |
No. of securities held after change |
19,830 |
Nature of changeExample: on-market trade, off-market trade, exercise ofoptions, issue of securities under dividend reinvestment plan,participation in buy-back |
On-market trade |
+ See chapter 19 for defined terms.
01/01/2011Appendix 3Y Page 1
Appendix 3Y
Change of Director’s Interest Notice
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in
this part.
Detail of contractNature of interest |
NilNil |
|---|---|
Name of registered holder(if issued securities) |
Nil |
Date of change |
Nil |
No. and class of securities to which interest relatedprior to changeNote: Details are only required for a contract in relation to which theinterest has changed |
Nil |
Interest acquired |
Nil |
Interest disposed |
Nil |
Value/ConsiderationNote: If consideration is non-cash, provide details and an estimatedvaluation |
Nil |
Interest after change |
Nil |
Part 3 – [+] Closed period
Were the interests in the securities or contractsdetailed above traded during a +closed period whereprior written clearance was required ? |
No |
|---|---|
If so, was prior written clearance provided to allowthe trade to proceed during this period ? |
Not Applicable |
If prior written clearance was provided, on what datewas this provided ? |
Not Applicable |
+ See chapter 19 for defined terms.
01/01/2011Appendix 3Y Page 2
More from CYCLOPHARM LIMITED
Director's Dealing
2026
May 7
Director's Dealing
2026
May 7
Declaration of Voting Results & Voting Rights Announcements
2026
May 7
AGM Information
2026
May 7
AGM Information
2026
May 7
AGM Information
2026
May 7
Board/Management Information
2026
May 3
Director's Dealing
2026
May 3
Major Shareholding Notification
2026
Apr 21
Capital/Financing Update
2026
Apr 19